 price
algn broadli posit revenu ep beat
guidanc also came investor fear ex-
coronaviru impact china though light given
mm revenu impact viru dichotomi
provid fodder bull bear bull point
conserv natur guidanc impact china
re-rat street number given move non-gaap
report bear worri light guidanc mask
competit threat china potenti elsewher
weigh growth see revenu growth like
high teen includ coronaviru impact
similar level case growth modest impact
gross margin also hit lower growth impact
ziyang facil somewhat moder
opex leverag howev estim
account chang continu monitor
coronaviru situat could potenti provid sourc
upsid estim given uncertainti
surround situat moder price target
reiter rate
note prior ep estim new ep estim non-
pleas see confer call note
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
china coronaviru
china revenu second biggest market grow
geograph gear toward shanghai beij coastal
distribut center china ship part asia
provinc geograph close wuhan
china growth similar china growth
chines govern extend lunar new year holiday unsur
diseas may stabil
potenti benefit china resort drastic measur
non-essenti medic dental oper ban time
prevent diseas spread
expect miss china case volum factor back unsur
stay isol wuhan could contain
yet move shanghai govern would take step
theyv taken wuhan
china coronaviru impact fewer case
mm less revenu
mm treatment plan capac gm impact
guidanc reflect period past
comment
volum increas emea america though outlook challeng
yoy increas op incom primarili reflect continu geograph
capital-expenditure mm primarili relat invest increas
align capac new facil
itero scanner volum also significantli
highlight sale forc expans advertis strategi america gp
expect flat saw rel consist price
scanner feedback great ex us
fda approv may come sometim
invisalign moder vs comprehens management see trade down
comprehens
focu maintain oper profit
sale invest advertis capabl continu drive us
management hasnt seen signific impact dtc hasnt seen
volum shift competitor price ration
management expect volum sequenti demand
expect fewer itero sale china though demand remain consist
end lt target
invisalign also low end lt target
itero growth fall growth rang
highlight expand capabl digit dentistri
expect see gm om improv
signific portion servic revenu
valuat methodolog base mix discount cash flow analysi rel valuat multipl
competit smaller competitor caus degre price pressur among invisalign lower util provid
least partial off-set improv cost managementan econom downturn slow consum spend caus
miss procedur whisper particularli us lose market share yet unknown premium competitor la
articl articl
time dissemin januari
analyst elizabeth anderson suzi yoon amato primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research
